NCT05932446View on ClinicalTrials.gov

A Study to Compare Two Formulations of LY3819469 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

November 7, 2023

Study Completion Date

November 7, 2023

Conditions

Healthy

Interventions

DRUG

LY3819469

Administered SC.

Trial Locations (1)

138623

Lilly Centre for Clinical Pharmacology, Singapore

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY